欢迎访问电脑商情在线! 请免费注册
分享到





位置:首页 > 智能终端 > 文传商讯

Vifor Pharma announces changes to its Executive Committee

作者: CN-INFO   责任编辑:文传商讯 2021-10-12 13:14:00
来源:文传商讯关键字:null

Executive committee members Lee Heeson and Gregory Oakes to leave the company for personal reasons
Succession planning ongoing

ST. GALLEN, Switzerland--()--Regulatory News:

AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR

Vifor Pharma Group today announced changes to its Executive Committee as current members Lee Heeson, President International, and Gregory Oakes, President North America, have decided to leave the company for personal reasons. Succession planning is currently underway and will be announced once the process has been concluded.

In parallel to these management changes, Vifor Pharma is pleased that Molly Painter is joining the company as President U.S., effective as of 18 October 2021. Molly has a proven track record of building and leading organizations across multiple therapeutic areas, and extensive experience in launching and commercializing products in the U.S..

Abbas Hussain, Chief Executive Officer of Vifor Pharma Group, commented: “I am delighted to welcome Molly Painter to Vifor Pharma. She brings a wealth of experience with over 20 years in the healthcare industry. I want to thank Lee and Greg for their contributions to Vifor Pharma and to the Executive Committee, especially for their commitment and leadership of the organization during the COVID-19 pandemic. I wish them the very best for their future endeavours, both professionally and personally.”

About Vifor Pharma Group
Vifor Pharma Group is a global pharmaceuticals company. It aims to become the global leader in iron deficiency, nephrology and cardio-renal therapies. The company is a partner of choice for pharmaceuticals and innovative patient-focused solutions. Vifor Pharma Group strives to help patients around the world with severe and chronic diseases lead better, healthier lives. The company develops, manufactures and markets pharmaceutical products for precision patient care. Vifor Pharma Group holds a leading position in all its core business activities and consists of the following companies: Vifor Pharma and Vifor Fresenius Medical Care Renal Pharma (a joint company with Fresenius Medical Care). Vifor Pharma Group is headquartered in Switzerland, and listed on the Swiss Stock Exchange (SIX Swiss Exchange, VIFN, ISIN: CH0364749348).

For more information, please visit viforpharma.com.

Contacts

Contact and further information:

Media Relations
Nathalie Ponnier
Global Head Corporate Communications
+41 79 957 96 73
media@viforpharma.com

Investor Relations
Julien Vignot
Head of Investor Relations
+41 58 851 66 90
investors@viforpharma.com

相关新闻:
网友评论(0) 评论仅代表网友个人观点,不代表CBINews观点。
CBINews网友您好,欢迎发表评论:(注册 后发表评论,可就本文发起辩论,将会获得更多关注)
 CBINews网友  注册邮箱:  

CBI 友情链接:

至顶网 |  腾讯科技 |  凤凰科技 |  商业伙伴 |  移动信息化 |  企业网 |  中国软件网 |  CIO时代网 |  更多>>

整合营销 |  CBINews刊例 |  《电脑商情报》刊例 |  联系方式 |  版权声明 |  友情链接

内容版权所有:电脑商情在线 北京米迪亚广告有限公司

地址:北京市海淀区中关村南大街28号6层 联系电话:(010)62178877-218

商务、内容合作QQ:15528356 客服电话:800-886-4689

电脑商情信息服务集团 成都华好网景科技有限公司

ICP证:川B2-20070068-5 川预审H8VZ-RBP6-X228-T60Z号 北京市公安局海淀分局备案编号:1101083710